Orson W Moe Selected Research

Citric Acid (Citrate)

1/2021	Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers.
1/2021	Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease.
1/2020	Novel Human Polymorphisms Define a Key Role for the SLC26A6-STAS Domain in Protection From Ca2+-Oxalate Lithogenesis.
2/2019	Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis.
12/2018	Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
1/2018	Incomplete Distal Renal Tubular Acidosis and Kidney Stones.
9/2014	Proximal tubule function and response to acidosis.
10/2013	SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis.
12/2011	Hypercalciuria associated with high dietary protein intake is not due to acid load.
10/2006	Biochemical and stone-risk profiles with topiramate treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orson W Moe Research Topics

Disease

31	Nephrolithiasis 01/2019 - 09/2002
18	Chronic Renal Insufficiency 07/2021 - 11/2010
17	Kidney Calculi (Kidney Stone) 01/2021 - 11/2002
16	Hypercalciuria 12/2018 - 12/2003
14	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2010
13	Fibrosis (Cirrhosis) 01/2022 - 01/2013
12	Acidosis 09/2021 - 07/2002
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 02/2004
8	Kidney Diseases (Kidney Disease) 07/2021 - 12/2012
7	Hyperphosphatemia 02/2019 - 01/2010
6	Reperfusion Injury 01/2022 - 12/2010
6	Hypertension (High Blood Pressure) 02/2019 - 09/2002
6	Familial Hypophosphatemia (Phosphate Diabetes) 12/2012 - 04/2005
5	Urolithiasis 11/2020 - 07/2010
5	Chronic Kidney Failure (Chronic Renal Failure) 06/2019 - 09/2002
5	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2018 - 11/2014
5	Insulin Resistance 01/2018 - 12/2002
5	Vascular Calcification 07/2014 - 01/2011
4	Hypophosphatemia 12/2021 - 02/2005
4	Hyperoxia 10/2021 - 10/2014
4	Inflammation (Inflammations) 01/2021 - 12/2012
4	Hypertrophy 01/2021 - 11/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
4	Obesity 12/2019 - 01/2014
4	Type 2 Diabetes Mellitus (MODY) 11/2013 - 05/2006
3	Sepsis (Septicemia) 01/2022 - 12/2019
3	Critical Illness (Critically Ill) 01/2022 - 01/2021
3	Renal Insufficiency (Renal Failure) 07/2021 - 09/2002
3	Hyperoxaluria (Oxaluria) 01/2018 - 10/2012
3	Gout 01/2018 - 12/2011
3	Hypercalcemia (Milk Alkali Syndrome) 01/2017 - 10/2014
3	Edema (Dropsy) 04/2016 - 10/2014
3	Cardiomegaly (Heart Hypertrophy) 06/2015 - 01/2013
3	Bone Resorption 11/2009 - 12/2003
2	Neoplasms (Cancer) 01/2022 - 12/2011
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2017
2	Body Weight (Weight, Body) 12/2019 - 05/2006
2	Albuminuria 06/2019 - 02/2013
2	Hyperparathyroidism 02/2019 - 03/2013
2	Urinary Calculi (Urinary Calculus) 12/2018 - 11/2004
2	Ischemia 04/2016 - 10/2011
2	Hyperuricemia 06/2015 - 11/2012
2	Hyperaldosteronism (Conn Syndrome) 10/2014 - 07/2004
2	Diarrhea 10/2012 - 12/2011

Drug/Important Bio-Agent (IBA)

24	Uric Acid (Urate)IBA 11/2020 - 09/2002
22	Phosphates (Orthophosphate)IBA 01/2022 - 02/2005
15	AcidsIBA 01/2021 - 07/2002
15	CalciumIBA 11/2020 - 07/2004
14	Citric Acid (Citrate)FDA LinkGeneric 01/2021 - 02/2004
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2010
13	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2003
11	CreatinineIBA 01/2022 - 09/2007
10	Ammonium CompoundsIBA 11/2020 - 12/2002
8	Fibroblast Growth Factor-23IBA 12/2021 - 03/2006
8	Calcium OxalateIBA 11/2020 - 02/2004
7	AlkaliesIBA 09/2021 - 01/2003
7	SaltsIBA 11/2020 - 09/2002
5	calcium phosphateIBA 01/2021 - 10/2006
5	MineralsIBA 01/2018 - 11/2009
4	OxalatesIBA 01/2021 - 10/2012
4	BuffersIBA 11/2020 - 11/2009
4	Vitamin D FDA LinkGeneric 01/2020 - 02/2005
4	AnionsIBA 01/2019 - 12/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2004
4	LipidsIBA 04/2016 - 11/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2014
3	Beclin-1IBA 01/2022 - 01/2018
3	Parathyroid Hormone (Parathormone)IBA 12/2021 - 04/2005
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 04/2016
3	Potassium Citrate FDA LinkGeneric 01/2021 - 01/2003
3	Protons (Proton)IBA 01/2019 - 07/2006
3	Hormones (Hormone)IBA 01/2019 - 03/2006
3	AmmoniaIBA 01/2019 - 02/2004
3	dirhodium tetraacetate (DRTA)IBA 01/2018 - 01/2016
3	PotassiumIBA 09/2017 - 01/2003
3	SodiumIBA 10/2013 - 10/2011
3	Insulin (Novolin)FDA Link 07/2011 - 09/2002
2	Peptides (Polypeptides)IBA 01/2022 - 01/2010
2	ReninIBA 08/2021 - 02/2019
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 12/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 01/2019
2	fibroblast growth factor 21IBA 06/2019 - 06/2018
2	Succinic Acid (Succinate)IBA 02/2019 - 10/2013
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2018 - 04/2016
2	Biological ProductsIBA 01/2018 - 02/2015
2	AntioxidantsIBA 01/2018 - 01/2013
2	hydroxide ionIBA 01/2018 - 02/2005
2	MagnesiumIBA 01/2018 - 08/2008
2	Estrogens (Estrogen)FDA Link 01/2017 - 11/2002
2	AdiponectinIBA 01/2017 - 02/2013
2	Conditioned Culture MediaIBA 04/2016 - 10/2014
2	Adenosine Triphosphatases (ATPase)IBA 11/2014 - 04/2005
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 09/2007
2	Messenger RNA (mRNA)IBA 10/2011 - 08/2007
2	Phosphate Transport Proteins (Phosphate Transporter)IBA 08/2011 - 09/2010
2	Topiramate (Topamax)FDA LinkGeneric 08/2011 - 10/2006
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 02/2011 - 01/2003

Therapy/Procedure

12	Therapeutics 09/2021 - 09/2002
3	Nephrectomy 01/2017 - 01/2014
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2019